Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction - ScienceDirect
.jpg "Programmed Cell Death Protein 1 (PD1) and Cancer")
Programmed Cell Death Protein 1 (PD1) and Cancer
Coupling programmed cell death 1-positive tumor-infiltrating T cells with anti-programmed cell death 1 antibody improves the efficacy of adoptive T-cell therapy - Cytotherapy
RCSB PDB - 6RPG: Structure of human Programmed cell death 1 ligand 1 (PD-L1) with inhibitor
Biomedicines | Free Full-Text | The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer | HTML
Programmed Death 1 Ligand 1 - an overview | ScienceDirect Topics
Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung Cancer (NSCLC) - ScienceDirect
RCSB PDB - 4ZQK: Structure of the complex of human programmed death-1 (PD-1) and its ligand PD-L1.
The programmed death ligand-1 (PD-L1) (B7-H1) pathway in regulation... | Download Scientific Diagram
Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect
Programmed death 1 (PD‐1) and ligand (PD‐L1) inhibitors in head and neck squamous cell carcinoma: A meta‐analysis - Levy - - World Journal of Otorhinolaryngology - Head and Neck Surgery - Wiley Online Library
Near-Infrared-II Nanoparticles for Cancer Imaging of Immune Checkpoint Programmed Death-Ligand 1 and Photodynamic/Immune Therapy | ACS Nano
Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy - Zhang - 2016 - Cancer Science - Wiley Online Library
Mechanism of anti-programmed death 1 (PD-1) receptor and... | Download Scientific Diagram
RCSB PDB - 6RPG: Structure of human Programmed cell death 1 ligand 1 (PD-L1) with inhibitor
The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity | The Journal of Immunology
Overexpression of Programmed Death Ligand 1 in Dendritic Cells Inhibits Allogeneic Lymphocyte Activation in Mice - Journal of Surgical Research
Efficacy and safety of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy: A systematic review and meta-analysis Pattanaik S, Dey S, Jaiswal N, Rohilla R, Singh SK, Mandal AK,
Figure 1 from Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade: A Key Player Against Various Cancers. | Semantic Scholar
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Fibrinogen cleavage products and Toll-like receptor 4 promote the generation of programmed cell death 1 ligand 2–positive dendritic cells in allergic asthma - Journal of Allergy and Clinical Immunology
Programmed cell death protein 1 - Wikipedia
Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold - ScienceDirect
Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium | Scientific Reports
Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor | Oncotarget
